Business · 1 sources covering this

Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue

Growth driven by recent product launches from CDMO portfolio and strong customer demand. Investing in differentiated technologies and capacity expansions.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

The HinduLean L·2h ago
Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue
Growth driven by recent product launches from CDMO portfolio and strong customer demand. Investing in differentiated technologies and capacity expansions.
Read at The Hindu →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/bfa944917901d95fe4ac832c0622b3606be6072f"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue"></iframe>

Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue

How 1 sources are covering this

Gland Pharma Q1 net surges 47% to ₹317 cr on higher revenue

More from Business

Jana Nayagan Box Office Collection Day 19: Vijay's Action Drama Continues Steady Run In Third Week, Check Earnings

CAG flags ₹6,603 cr land cost overrun, financial stress at Bangalore Metro

Milky Mist Dairy Food raises ₹465 cr from 19 anchor investors ahead of IPO

Life insurers’ new business premium rose 20% in July to ₹47,000 crore

Reader

Trust & legal

Across the network